Melanoma Molecular Maps Projects

Padova

The IPD is a multicenter database, which gathers anonymized information about clinical and histopathological features as well as availability of biological material regarding patients with cutaneous melanoma enrolled by centers that participate in this project.
A systematic collection of the scientific knowledge regarding the development of targeted therapy for melanoma. Since data are gathered in a computationally compatible fashion, the database can be utilized for the identification of prevalent therapeutic hypotheses based on the available evidence and for ranking treatments based on the patient's molecular profile (drug ranking system).
Inspired to the principles of functional interactomics, this is a collection of schematic figures depicting the molecular pathways involved in cancer development and progression, with particular regard to melanoma. A close-to-hand visual guide to navigate in the ever-growing complexity of cancer molecular biology.

Search the site


Risk Assessment Tools

TNM Staging System | Total Dermoscopy Score | Thin Melanoma Prognosis |


Melanoma News

Sphingosine metabolism as a therapeutic target in cutaneous melanoma.
Dany M
Transl Res. 2017 May 4;():.
PMID: 28528915 [PubMed - as supplied by publisher]

Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study).
McArthur GA, Mohr P, Ascierto PA, Arance A, Banos Hernaez A, Kaskel P, Weichenthal M, Shinde R, Stevinson K
Oncologist. 2017 May 19;():.
PMID: 28526721 [PubMed - as supplied by publisher]

Emotional distress and health-related quality of life among cutaneous melanoma follow-up outpatients: the role of self-perception of body image and surgical scarring.
Bassino S, Ribero S, Miniotti M, Picardi A, Caliendo V, Castelli L, Torta R, Macripò G, Leombruni P
Eur J Dermatol. 2017 May 19;():.
PMID: 28524051 [PubMed - as supplied by publisher]

Genetic Variants in the Genes Encoding Rho GTPases and Related Regulators Predict Cutaneous Melanoma-specific Survival.
Liu S, Wang Y, Xue W, Liu H, Xu Y, Shi Q, Wu W, Zhu D, Amos CI, Fang S, Lee JE, Hyslop T, Li Y, Han J, Wei Q
Int J Cancer. 2017 May 16;():.
PMID: 28510328 [PubMed - as supplied by publisher]

Cutaneous melanoma in women.
Roh MR, Eliades P, Gupta S, Grant-Kels JM, Tsao H
Int J Womens Dermatol. 2017 Mar;3(1 Suppl):S11-S15.
PMID: 28492033 [PubMed - in process]


NCBI's Disclaimer and Copyright notice